CN106511962A - Compound Tibetan medicine health care product - Google Patents

Compound Tibetan medicine health care product Download PDF

Info

Publication number
CN106511962A
CN106511962A CN201710032146.8A CN201710032146A CN106511962A CN 106511962 A CN106511962 A CN 106511962A CN 201710032146 A CN201710032146 A CN 201710032146A CN 106511962 A CN106511962 A CN 106511962A
Authority
CN
China
Prior art keywords
care product
compound recipe
tibetan medicinal
medicinal health
health
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201710032146.8A
Other languages
Chinese (zh)
Inventor
尼玛次仁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
TIBETAN TRADITIONAL MEDICAL COLLEGE
Original Assignee
TIBETAN TRADITIONAL MEDICAL COLLEGE
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by TIBETAN TRADITIONAL MEDICAL COLLEGE filed Critical TIBETAN TRADITIONAL MEDICAL COLLEGE
Priority to CN201710032146.8A priority Critical patent/CN106511962A/en
Publication of CN106511962A publication Critical patent/CN106511962A/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/41Crassulaceae (Stonecrop family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2095Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

A compound Tibetan medicine health care product is prepared by the following raw materials: 40-150 g of rhodiola crenulata, 2-45 g of dried ginger, 120 g of rock candy, 10-50 g of dextrin and 50-100 g of sucrose. A preparation method for the compound Tibetan medicine health care product comprises the following steps that material selecting, cleaning and drying are conducted; after being smashed to pass a 100-mesh screen, the raw materials are proportionally and uniformly mixed, and a mixture is prepared; and tabletting forming is conducted, specifically, 95% of ethanol is added into the mixture, tabletting is conducted under the pressure of 70-90 N and under the conditions of controlling the particle size to be 18-20 mesh and controlling the moisture content to be 4%-6%, the core temperature is 50 DEG C, the rotation speed is controlled to be 7-9 rpm, and the health care product is prepared. A Tibetan medicine composite has the advantages that obvious anti-hypoxic and anti-fatigue effects are achieved, the formula and the preparation process are simple, and using is convenient.

Description

A kind of compound recipe Tibetan medicinal health-care product
Technical field
The invention belongs to field of health care food, is related to a kind of compound recipe Tibetan medicinal health-care product, more particularly to a kind of Tibetan medicine material is bright red Complex health care product of anti-hypoxia based on Herba hylotelephii erythrosticti and preparation method thereof.
Background technology
At present, developing rapidly with social economy, the living environment of people constantly deteriorate, meanwhile, the life section of people Substantially quickening is played, operating pressure is remarkably reinforced, and most people is in sub-health state because of reasons such as environment, fatigues.In order to alleviate life Operating pressure living, increasing people are walked out city, come into plateau out on tours.But people from Plain move into plateau after, muscle power and Mental activity ability will be decreased obviously.If using maximal oxygen consumption as evaluation index, during more than height above sea level 1600m, often raising 300m maximal oxygen consumptions decline 3.2%.Therefore, study fatigue alleviating state, hypoxia mobility is improved for guarantee body is good for Health and the work efficiency improved under hypoxia condition are very significant.
Radix Rhodiolae system Crassulaceae rhodiola medicinal and edible plants resource, great majority are grown in 2500~5000m's of height above sea level Alpine environment, it has the various biologicals such as resisting fatigue, anti-hypoxia, defying age, radioprotective activity, as Radix Rhodiolae nature and flavor are put down With, even if take throughout the year, be also not in the side effect such as xerostomia, lip be dry, therefore, Radix Rhodiolae has been widely used for treating plateau Disease, resisting fatigue etc..In China, Rhodida plant species is more, distribution is wide, and resource is relatively enriched, and kind is numerous, and (China there are about 70 It is various).The kind of Radix Rhodiolae is different, and its chemical composition and biologic activity are also variant, at present except to Rhodiola tibetica (Hook. f. et Thoms.) S. H. Fu, high mountain Radix Rhodiolae etc. has been carried out outside the utilization of resources, to other species resources, if any " plateau Radix Ginseng ", the big premium of " plant gold " laudatory title The utilization of Herba hylotelephii erythrosticti is also far from enough.
The content of the invention
The purpose of the present invention is to develop a kind of compound recipe Tibetan medicine as primary raw material with Tibetan medicine " plateau Radix Ginseng " Radix Rhodiolae to protect Strong product.This compound recipe Tibetan medicinal health-care product has obvious anti-hypoxia, antifatigue effect, and formula and preparation process is simple, user Just.
The present invention provides a kind of compound recipe Tibetan medicinal health-care product, and it is prepared from by following raw materials and adjuvant:
40~150g of Radix Rhodiolae;2~45g of Rhizoma Zingiberiss;Crystal sugar 120g;10~50g of dextrin;50~100g of sucrose.
Preferably, the formula of compound recipe Tibetan medicinal health-care product is 60~130g of Radix Rhodiolae;5~40g of Rhizoma Zingiberiss;Crystal sugar 120g; 30~50g of dextrin;60~80g of sucrose.
Preferably, the formula of compound recipe Tibetan medicinal health-care product is Radix Rhodiolae 100g;Rhizoma Zingiberiss:35g;Crystal sugar 120g;Dextrin 40g;Sucrose 70g.
The compound recipe Tibetan medicinal health-care product that the present invention is provided, activity of the Radix Rhodiolae by the internal various metabolic enzymes of regulation, energy Make the elimination of sugared anaerobic, one lactic acid of intermediate link of aerobic metabolism energy supplying system tend to optimized development, formed between good It is good to circulate, the energy supply level of body carbohydrate metabolism system is improve, the ratio of protein metabolism energy supply is reduced, oxygen consumption is reduced, clearly Except free radical, increase activities of antioxidant enzymes, suppress or reduce lipid peroxidation etc., so as to the blood stream for suppressing anoxia to cause Become to learn and change, so as to improve anti-anoxia ability.
Medical material of the Rhizoma Zingiberiss as medicine-food two-purpose, with warming spleen and stomach for dispelling cold, Back to Yang Tongmai, eliminating dampness dissolving phlegm, effect of warming the lung to resolve fluid-retention.
Medical material of the crystal sugar as medicine-food two-purpose, with invigorating the spleen and replenishing QI, stomach function regulating lung moistening.Cough-relieving is coughed, effect of resolving sputum saliva.
Present invention also offers a kind of preparation method of compound recipe Tibetan medicinal health-care product, comprises the following steps:
Step 1:Sorting, cleaning, drying, screen raw material, remove impurity and pest and disease damage, use and meet the clear of living-hygienic standard Water flushes out dust and filth, is dried, stores for future use at 37~54 DEG C;
Step 2:Crush, mix, after Radix Rhodiolae, Rhizoma Zingiberiss and crystal sugar are each crushed, after crossing 60~120 mesh sieves, press Ratio uniform is mixed and made into mixture;
Step 3:Compression molding, adds 95% ethanol in mixture, under the pressure of 70~90N, controls particle Spend for tabletting under conditions of 18~20 mesh, moisture 4~6%, piece heart temperature is 50 DEG C, and rotating speed is controlled in 7~9rpm, is obtained Health product.
Preferably, the baking temperature described in step 1 is 45 DEG C.
Preferably, the crushing elder generation coarse crushing of step 2 Radix Rhodiolae, micronizing is carried out, (breaking cellular wall, its effect is more It is good).
Preferably, the micronizing adopts superfine comminution at low temperature.
Preferably, the compression molding, under 80N pressure, it is 20 mesh, the condition of moisture 5% to control grain graininess Lower sheeting, piece heart temperature are 50 DEG C, and rotating speed is controlled in 8rpm, and health product are obtained.
The compound recipe Tibetan medicinal health-care product is can be applicable in anti-hypoxia, anti-fatigue health-product containing.
Preferably, control in 5~10min the compound recipe Tibetan medicinal health-care product disintegration.
The primary raw material Radix Rhodiolae of compound recipe Tibetan medicinal health-care product of the present invention screens tight in more than height above sea level 4500m is grown in The Tibetan medicine Radix Rhodiolae of cold, anoxia, strong daylight, contamination-freely band, category pure natural, free of contamination green plantss, protects to human body Strong effect more preferably, and has no toxic side effect, without analeptic, using reliability.The compound recipe Tibetan medicinal health-care product have obvious anti-hypoxia, Antifatigue effect, and formula and preparation process is simple, advantage easy to use.
Specific embodiment
Preferably to explain the present invention, it is described in detail below by embodiments of the invention.
Embodiment 1
A kind of compound recipe Tibetan medicinal health-care product, weighs raw material in following ratios:
Radix Rhodiolae 100g;Rhizoma Zingiberiss:35g;Crystal sugar 120g;DEXTRIN g;Sucrose 70g.
The manufacture method of compound recipe Tibetan medicinal health-care product buccal tablet:
Step 1:Sorting, cleaning, drying, screen raw material, remove impurity and pest and disease damage, use and meet the clear of living-hygienic standard Water flushes out dust and filth, is dried, stores for future use at 45 DEG C;
Step 2:Crush, mix, after Radix Rhodiolae, Rhizoma Zingiberiss and crystal sugar are each crushed, after crossing 60 mesh sieves, make mixing Thing;
Step 3:Compression molding, adds 95% ethanol in mixture, and under the pressure of 70N, controlling grain graininess is Tabletting under conditions of 20 mesh, moisture 6%, piece heart temperature are 50 DEG C, and rotating speed is controlled in 9rpm, and compound recipe Tibetan medicinal health-care product is obtained Buccal tablet, its disintegration are controlled in 5~10min.
Embodiment 2
A kind of compound recipe Tibetan medicinal health-care product, weighs raw material in following ratios:
Radix Rhodiolae 40g;Rhizoma Zingiberiss 2g;Crystal sugar 120g;Dextrin 10g;Sucrose 50g.
The manufacture method of compound recipe Tibetan medicinal health-care product buccal tablet:
Step 1:Sorting, cleaning, drying, screen raw material, remove impurity and pest and disease damage, use and meet the clear of living-hygienic standard Water flushes out dust and filth, is dried, stores for future use at 37 DEG C;
Step 2:Crush, mixing, by the coarse crushing of the crushing of Radix Rhodiolae Radix Rhodiolae elder generation, carrying out micronizing, After Rhizoma Zingiberiss and crystal sugar are each crushed, after crossing 120 mesh sieves, mixture is made;
Step 3:Compression molding, adds 95% ethanol in mixture, and under the pressure of 90N, controlling grain graininess is Tabletting under conditions of 18 mesh, moisture 4%, piece heart temperature are 50 DEG C, and rotating speed is controlled in 7rpm, and compound recipe Tibetan medicinal health-care product is obtained Buccal tablet.
Embodiment 3
A kind of compound recipe Tibetan medicinal health-care product, weighs raw material in following ratios:
Radix Rhodiolae 150g;Rhizoma Zingiberiss 45g;Crystal sugar 120g;Dextrin 50g;Sucrose 100g.
Step 1:Sorting, cleaning, drying, screen raw material, remove impurity and pest and disease damage, use and meet the clear of living-hygienic standard Water flushes out dust and filth, is dried, stores for future use at 54 DEG C;
Step 2:Crush, mixing, by the coarse crushing of Radix Rhodiolae elder generation, then using superfine comminution at low temperature, Rhizoma Zingiberiss and crystal sugar are each From after crushing, after crossing 100 mesh sieves, mixture is made;
Step 3:Compression molding, in mixture add 95% ethanol, under 80N pressure, control grain graininess be 20 mesh, Tabletting under conditions of moisture 5%, piece heart temperature are 50 DEG C, and rotating speed is controlled in 8rpm, and compound recipe Tibetan medicinal health-care product buccal tablet is obtained.
Embodiment 4
A kind of compound recipe Tibetan medicinal health-care product, weighs raw material in following ratios:
Radix Rhodiolae 130g;Rhizoma Zingiberiss 5g;Crystal sugar 120g;Dextrin 50g;Sucrose 80g.
Step 1:Sorting, cleaning, drying, screen raw material, remove impurity and pest and disease damage, use and meet the clear of living-hygienic standard Water flushes out dust and filth, is dried, stores for future use at 45 DEG C;
Step 2:Crush, mixing, by the coarse crushing of Radix Rhodiolae elder generation, then using superfine comminution at low temperature, Rhizoma Zingiberiss and crystal sugar are each From after crushing, after crossing 120 mesh sieves, mixture is made;
Step 3:Compression molding, in mixture add 95% ethanol, under 90N pressure, control grain graininess be 20 mesh, Tabletting under conditions of moisture 5%, piece heart temperature are 50 DEG C, and rotating speed is controlled in 8rpm, and compound recipe Tibetan medicinal health-care product buccal tablet is obtained.
Embodiment 5
A kind of compound recipe Tibetan medicinal health-care product, weighs raw material in following ratios:
Radix Rhodiolae 60g;Rhizoma Zingiberiss 40g;Crystal sugar 120g;Dextrin 30g;Sucrose 60g.
Step 1:Sorting, cleaning, drying, screen raw material, remove impurity and pest and disease damage, use and meet the clear of living-hygienic standard Water flushes out dust and filth, is dried, stores for future use at 45 DEG C;
Step 2:Crush, mixing, by the coarse crushing of Radix Rhodiolae elder generation, then using superfine comminution at low temperature, Rhizoma Zingiberiss and crystal sugar are each From after crushing, after crossing 100 mesh sieves, mixture is made;
Step 3:Compression molding, in mixture add 95% ethanol, under 80N pressure, control grain graininess be 18 mesh, Tabletting under conditions of moisture 4%, piece heart temperature are 50 DEG C, and rotating speed is controlled in 8rpm, and compound recipe Tibetan medicinal health-care product buccal tablet is obtained.
Embodiment 6
Compound recipe Tibetan medicinal health-care product buccal tablet is obtained to embodiment 1 and carries out anoxia tolerant function evaluation experimental.
Positive drug sample:Rhodiola wallichiana var. cholaensis capsule, is provided by Kangyuan Pharmaceutical Co., Ltd., Jiangsu Prov, Chinese medicines quasi-word: Z20040023,30/box, lot number 150402.
Laboratory animal:Cleaning grade male mouse of kunming, 18~22g of weight are limited up to large biotechnology by Sichuan Province Chengdu Company provides, and production licence number is SCXK (river) 2015-030.Feedstuff is provided by same unit.
Experimental apparatus:LQ-A6002 electronic balances, Rui'an City An Te Weighing Equipment Co., Ltd.;Sartorius BP121s Electronic balance, Beijing Sai Duolisi scientific instrument company limited (degree of accuracy 0.0001g);Stopwatch;250ml ground wide-mouth bottles.
Experiment reagent:Sodium nitrite (Chengdu Ke Long chemical reagents factory), sodica calx (Beijing Dare Li Nashihuichang);It is all Intellectual circle.
1st, test method
After Animal adaptability is fed 3 days, laboratory animal is randomly divided into into 8 groups:Blank control group;Positive drug group (0.912g/kg BW are approximately equivalent to 12 times of human body recommended amounts);High, medium and low dosage group (the dosage of tested anti-hypoxia buccal tablet Respectively 6.6g/kg BW, 3.3g/kg BW, 1.65g/kg BW, are approximately equivalent to 12 times, 6 times, 3 times of quantity), often Group 10.Once, gavage amount is 20ml/kg BW to daily gavage, and successive administration 7 days weighed a body weight per 3 days.
Normal pressure anoxia tolerance test:1 hour after last gavage, each group mice is respectively put into and fills 10g sodica calx In 250ml port grinding bottles (1 per bottle), bottleneck is sealed with vaseline, cover tightly, be allowed to air tight, immediately timing, with respiratory arrest to refer to Mark, records the time of mice death because of anoxia.
Sodium nitrite poisoning survival test:1 hour after last gastric infusion, each group animal presses 20ml/kg BW abdominal cavities Injection 2% (m/v) inferior sodium nitrate solution, immediately timing record animal survival time.
Acute cerebral ischemia hypoxia test:1 hour after last gastric infusion, after animal is with ether light anaesthesia, with shears certainly Cervical region breaks end, to dwell time of breathing of dehiscing after breaking end by stopwatch record mice immediately.
Experimental data is counted:Test data statistics is using 19.0 software processes of SPSS.Using single factor test side's com-parison and analysis group Between difference, inspection level α=0.05, if group difference is statistically significant, and variance is compared two-by-two with Dunnett methods together Compared with;If heterogeneity of variance, compared with Dunnett ' s T3 methods two-by-two.
2nd, result and analysis
Normal pressure anoxia tolerance test:
As a result as shown in table 1, before and after test, animal body quality is without significant difference (P>0.05).It is each compared with blank control group There were significant differences for experimental group prolonged survival period (P < 0.05).
1 anti-hypoxia buccal tablet mice normal pressure anoxia tolerance test result of table (N=10)
Sodium nitrite poisoning survival test:As a result as shown in table 2, before and after test, animal body quality is without significant difference (P> 0.05).Compared with blank control group, each experimental group prolonged survival period is in addition to except B middle dose groups, there were significant differences (P < 0.05), its Remaining group is without significant difference (P > 0.05).
2 anti-hypoxia buccal tablet mice sodium nitrite of table poisoning survival test result (N=10)
Acute cerebral ischemia hypoxia test:As a result as shown in table 3, before and after test, animal body quality is without significant difference (P> 0.05).Compared with blank control group, there were significant differences (P < 0.05) for each experimental group prolonged survival period.
3 anti-hypoxia buccal tablet Acute cerebral ischemia in mice hypoxia test result of table (N=10)
As can be seen that when anti-hypoxia tolerance functional evaluation experimental verification is carried out, compared with positive control medicine, compound recipe Tibetan medicinal health-care product buccal tablet anti-anoxia ability significantly improves (P < 0.05).In Resistance to anoxia, sodium nitrite poisoning survival examination Test, in acute cerebral ischemia hypoxia test, by test product each group compared with blank group, obvious difference is statistically significant;Obtain To result of the test in, high dose and middle dosage effect are optimum.

Claims (10)

1. a kind of compound recipe Tibetan medicinal health-care product, it is characterised in which is made up of following components:
40~150g of Radix Rhodiolae;2~45g of Rhizoma Zingiberiss;Crystal sugar 120g;10~50g of dextrin;50~100g of sucrose.
2. compound recipe Tibetan medicinal health-care product according to claim 1, it is characterised in which is made up of following components:
60~130g of Radix Rhodiolae;5~40g of Rhizoma Zingiberiss;Crystal sugar 120g;30~50g of dextrin;60~80g of sucrose.
3. compound recipe Tibetan medicinal health-care product according to claim 1, it is characterised in which is made up of following components:
Radix Rhodiolae 100g;Rhizoma Zingiberiss:35g;Crystal sugar 120g;DEXTRIN g;Sucrose 70g.
4. according to any one in claims 1 to 3 compound recipe Tibetan medicinal health-care product preparation method, it is characterised in that include Following steps:
Step 1:Sorting, cleaning, drying, screen raw material and remove impurity and pest and disease damage, with the clear water for meeting living-hygienic standard Flush out dust and filth, dry in the shade or 37~54 DEG C at be dried, store for future use;
Step 2:Crush, mix, after Radix Rhodiolae, Rhizoma Zingiberiss and crystal sugar are each crushed, after crossing 60~120 mesh sieves, in proportion Mixture is mixed and made into uniformly;
Step 3:Compression molding, adds 95% ethanol in mixture, and under the pressure of 70~90N, controlling grain graininess is Tabletting under conditions of 18~20 mesh, moisture 4~6%, piece heart temperature are 50 DEG C, and rotating speed is controlled in 7~9rpm, and health care is obtained Product.
5. the preparation method of compound recipe Tibetan medicinal health-care product according to claim 4, it is characterised in that be dried described in step 1, Its baking temperature is 45 DEG C.
6. the preparation method of compound recipe Tibetan medicinal health-care product according to claim 4, it is characterised in that crush described in step 2, The crushing of Radix Rhodiolae first carries out coarse powder, is carrying out micronizing.
7. the preparation method of compound recipe Tibetan medicinal health-care product according to claim 6, it is characterised in that the micronizing is adopted Superfine comminution at low temperature.
8. the preparation method of compound recipe Tibetan medicinal health-care product according to claim 4, it is characterised in that tabletting described in step 3 into Type, under 80N pressure, controls grain graininess for 20 mesh, tabletting under conditions of moisture 5%, and piece heart temperature is 50 DEG C, rotating speed Control is obtained health product in 8rpm.
9. compound recipe Tibetan medicinal health-care product described in any one in claims 1 to 3, it is characterised in which is applied to anti-hypoxia, anti-tired In labor health product.
10. the compound recipe Tibetan medicinal health-care product prepared by the preparation method according to any one in claim 4~8, its feature exist In its disintegration is 5~10min.
CN201710032146.8A 2017-01-17 2017-01-17 Compound Tibetan medicine health care product Pending CN106511962A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201710032146.8A CN106511962A (en) 2017-01-17 2017-01-17 Compound Tibetan medicine health care product

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710032146.8A CN106511962A (en) 2017-01-17 2017-01-17 Compound Tibetan medicine health care product

Publications (1)

Publication Number Publication Date
CN106511962A true CN106511962A (en) 2017-03-22

Family

ID=58335670

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201710032146.8A Pending CN106511962A (en) 2017-01-17 2017-01-17 Compound Tibetan medicine health care product

Country Status (1)

Country Link
CN (1) CN106511962A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1426787A (en) * 2001-12-20 2003-07-02 肖永良 Health care mixture for antifatigne and enhancing immunity
CN102526656A (en) * 2010-12-15 2012-07-04 西藏藏医学院 Medicament or health-care food composition for preventing or/and treating erythremia
CN104106826A (en) * 2014-06-19 2014-10-22 青海亿百加农业技术有限公司 Rhodiola beverage and preparation method thereof
CN104840920A (en) * 2015-05-18 2015-08-19 彭婷婷 Traditional Chinese medicine product for preventing altitude stress and preparation method thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1426787A (en) * 2001-12-20 2003-07-02 肖永良 Health care mixture for antifatigne and enhancing immunity
CN102526656A (en) * 2010-12-15 2012-07-04 西藏藏医学院 Medicament or health-care food composition for preventing or/and treating erythremia
CN104106826A (en) * 2014-06-19 2014-10-22 青海亿百加农业技术有限公司 Rhodiola beverage and preparation method thereof
CN104840920A (en) * 2015-05-18 2015-08-19 彭婷婷 Traditional Chinese medicine product for preventing altitude stress and preparation method thereof

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
温振英主编: "《小儿常见病的食物疗法》", 30 December 1991 *
郭慧玲等主编: "《药剂学》", 28 February 2014 *
鲁耀邦等主编: "《中药学》", 30 December 2015 *

Similar Documents

Publication Publication Date Title
CN101595988B (en) Health-care food preparation for alleviating fatigue and preparation method thereof
CN101015665A (en) Medicine composition with sleeping improving function, preparing process and quality controlling means thereof
CN105595351B (en) A kind of nutrition product with stable state regulating and controlling blood sugar and its preparation method and application
CN104013733B (en) Chitosan composition for prevention and treatment of chemical liver injury and preparation method thereof
CN100401918C (en) Anti-fatigue and health-care food, and its prepn. method
CN106511962A (en) Compound Tibetan medicine health care product
CN100574757C (en) The compositions of acetylcysteine or its salt and anti-infectives
CN109010514A (en) Composition, health care product and the preparation method of altitude sickness prevention
CN1709150A (en) Life-cultivating paste nourishing agent and its processing method
CN1223885A (en) Digestive appetitive assimilation-promoting Chinese medicine preparation
CN101406623A (en) Health-care wine for males
CN104432057B (en) A kind of health food with endocrine regulation function and preparation method thereof
CN1180822C (en) Huafeng pill
CN108323762B (en) Selenium-rich composition and preparation, preparation method and application thereof
CN107029162A (en) Pharmaceutical composition, preparation method and the preparation of enhancing development
CN114533817A (en) Composition for improving blood sugar and/or blood fat and application thereof
CN102327304B (en) Drug for preventing and controlling chronic mountain sickness and preparation method thereof
CN105854002A (en) Polypeptide powder composition and tablet and preparation method thereof
CN100381152C (en) Medicinal granules of nourishing Yin and tonifying stomach, capsule and tablet preparing method
CN109893603A (en) It is a kind of to improve the composition of men's health, preparation method and applications
CN100377661C (en) Process for preparing micrometer sugared shentiandiyinluyi, kidney invigorating and fatigue reducing wine
CN1513503A (en) Medicinal composition for preventing and treating lead toxication
CN114053390B (en) Traditional Chinese medicine composition with hypoxia tolerance and preparation method and application thereof
CN1074812A (en) The production technology of blood fat reducing compound bee-glue preparation
CN102599312A (en) Oligosaccharide Panax notoginseng sweet tea and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20170322